{
  "docId": "019dd923-622b-71dc-a6dc-b34895e14e2f",
  "docSlug": "3d2fbe2d392f",
  "documentTitle": "Elanco Animal Health (ELAN)",
  "authorId": "21_Ancora",
  "authorName": "Ancora",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 36,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a timeline to contrast repeated management rhetoric with lack of results.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "timeline_visual",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6dc-b34895e14e2f/20",
  "deckHref": "/decks/019dd923-622b-71dc-a6dc-b34895e14e2f",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6dc-b34895e14e2f.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6dc-b34895e14e2f#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.94,
        "x": 0.03,
        "y": 0.028
      },
      "kind": "callout",
      "text": "Collection of six quotes from 2020-2023 referencing 'inflection point'",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e006af1f-8945-4c3b-a1d9-86349ac9a32a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Despite Mr. Simmons’ claims that growth and value creation are just around the corner, margins have not improved and the synergies from the Bayer transaction have yet to be realized.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-fb91-749f-a6b8-80c5ae24c206",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.94,
        "x": 0.03,
        "y": 0.5
      },
      "kind": "diagram",
      "text": "Timeline of years 2020-2023",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "039fa902-b490-488a-bc0f-365b82f28036",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.94,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "Despite Mr. Simmons’ claims that growth and value creation are just around the corner, margins have not improved and the synergies from the Bayer transaction have yet to be realized. Leadership’s hollow promises have resulted in the erosion of shareholder confidence.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c311d32-dc22-4317-95c5-b6fe92731566",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"Elanco stands at an inflection point, positioned for accelerated long-term value creation for shareholders and society.\" — 12/15/2020, 2020 Investor Day; \"So again, I think we're at an inflection point...of value creation.\" — 12/1/2020, Evercore ISI 3rd Annual HealthCONx Conference; \"We're now at an inflection point for growth.\" — 5/19/2021, 2021 Annual Meeting; \"...we stand as a strategic global leader with a robust, diverse and durable portfolio, more access to the world's animals and at an inflection point to grow, innovate and deliver the next era of value.\" — 1/12/2021, 39th Annual JPMorgan Virtual Healthcare Conference; \"I think the headline is we are at an inflection point as a company, second-largest independent animal health company.\" — 9/11/2023, Morgan Stanley 21st Annual Global Healthcare Conference; \"...we expect to see an inflection point in 2024.\" — 5/9/2023, Q1 2023 Earnings Call",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-fb91-749f-a6b8-86cb8621d488",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.01,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Company filings. Ancora Alternatives LLC",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38934a81-d549-4a7c-89e0-6c61124ab560",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Leadership Has Made Claims of Being at an “Inflection Point” for Years",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72135f48-4ced-4bd1-898a-183f958716c1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "3f60e4bf-8399-4976-8b50-a89297f0a246",
      "evidence": "Contrasting repeated CEO claims of 'inflection point' with the stated lack of margin improvement.",
      "confidence": 0.95
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 12,
      "beatId": "95db9939-3622-4c08-a313-7d47199773ab",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Struggle",
      "beatSlug": "overcoming-monster-the-struggle",
      "evidence": "The document details the struggles under the current leadership and Board.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 23,
      "from": 17,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "d1a41116-3663-4be0-8420-9766159723c2",
      "evidence": "The document highlights consistent underperformance and poor execution.",
      "position": 0,
      "objective": "Identify patterns of underperformance and poor governance.",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}